Generic competition · all medicines · read 12 November 2026
Is there a generic of Lorazepam, and who makes it?
Lorazepam appears in 5 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 15 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. This is the Orange Book's listing, not a forecast.
Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.
- Lorazepam appears in 5 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 15 generic makers listed as marketed across them.
- 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Tablet, Oral
Four or more generic makers listed
Brand listed as marketed: Ativan. 8 generic makers with 24 generic products listed as marketed; the first generic approval is dated 9 August 1985.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Sandoz Inc | 21 April 1987 | 3 |
| Watson Laboratories Inc | 31 October 1991 | 3 |
| Sun Pharmaceutical Industries Ltd | 29 August 2001 | 3 |
| Oxford Pharmaceuticals Llc | 10 May 2006 | 3 |
| Ani Pharmaceuticals Inc | 13 December 2006 | 3 |
| Leading Pharma Llc | 30 July 2007 | 3 |
| Aurobindo Pharma Ltd | 22 December 2017 | 3 |
| Graviti Pharmaceuticals Private Ltd | 24 July 2025 | 3 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Injectable, Injection
Four or more generic makers listed
Brand listed as marketed: Ativan. 4 generic makers with 5 generic products listed as marketed; the first generic approval is dated 12 April 1994.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Hospira Inc | 12 April 1994 | 2 |
| Rising Pharma Holdings Inc | 23 July 1998 | 1 |
| International Medication Systems Ltd | 15 November 2004 | 1 |
| Fresenius Kabi Usa Llc | 18 November 2024 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Concentrate, Oral
Generics listed, no brand listed
No brand application is listed. 3 generic makers with 3 generic products listed as marketed; the first generic approval is dated 28 June 1991.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Hikma Pharmaceuticals Usa Inc | 28 June 1991 | 1 |
| Amneal Pharmaceuticals | 23 December 2009 | 1 |
| Pharmaceutical Assoc Inc | 15 June 2010 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Capsule, Extended Release, Oral
Brand listed, no generic listed as marketed
Brand listed as marketed: Loreev Xr. No generic is listed as marketed.
Patents and exclusivities still listed
- 8 January 2034Patent 8999393 drug product
Solution, Oral
Nothing listed as marketed
No brand application is listed. No generic is listed as marketed (1 generic product listed as discontinued).
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.